Spotlight
Clinical
Video Series
News
Partners
CME/CE
Subscribe
Higher Risk of Cancer Recurrence Unlikely With TNFi Therapy in RA
One caveat: because several risk estimates reached higher confidence intervals, a clinically meaningful risk cannot be completely ruled out.
Reference1. Raaschou P, Söderling J, Turesson C, Askling J; ARTIS Study Group. Tumor necrosis factor inhibitors and cancer recurrence in Swedish patients with rheumatoid arthritis: a nationwide population-based cohort study. Ann Intern Med. 2018;169:291-299. doi: 10.7326/M17-2812.
Related Videos
Related Content
